Chippenham, UK – January 17 2008: Vectura Group plc (LSE: VEC) (“Vectura”), the pulmonary product development company focused on lung and neurological diseases, is today issuing its Interim Management Statement (“IMS”). This IMS relates to the three month period from 1 October 2007 to 31 December 2007 and contains information up to the publication of this IMS (“the period”).
